Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

AstraZeneca files NDA for zolmitriptan in Japan

April 14, 2000

Immune Response identifies genes involved in nerve repair

April 14, 2000

Chirocaine launched in U.S. for anesthesia and pain management

April 14, 2000

Butyrylcholinesterase inhibition heralded as potential new treatment strategy for AD

April 13, 2000

Keppra receives Swiss approval for treatment of epilepsy

April 12, 2000

Roche describes new ligands for the opioid-like receptor OFQ with a piperidine structure

April 12, 2000

Pfizer's new opioid receptor ligands claimed for use in painful, inflammatory and other disorders

April 12, 2000

Memantine improves cognition in vascular dementia patients

April 12, 2000

Atlantic submits IND for CT-3 to FDA; phase I trials to commence in France

April 12, 2000

Rasagiline successfully completes phase III trial in PD

April 11, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...